Crossref
Effects of Azelastine on Glioblastoma Cells
Anticancer Research · 2025
DOI: 10.21873/anticanres.17645 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, 2025. Verfasst von Yuki Uemichi und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Hyogo Medical University, Kobe, Japan. Hauptthemen laut MEDLINE: Glioblastoma, Phthalazines, Brain Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
GlioblastomaPhthalazinesBrain NeoplasmsHumansCell Line, TumorCell ProliferationCell SurvivalTemozolomideApoptosisDoxorubicin
Stichwörter der Autor:innen
Azelastineanticancer drugdoxorubicinglioblastomatemozolomide
Substanzen
PhthalazinesazelastineTemozolomideDoxorubicin
Autor:innen und Institutionen
- School of Pharmacy, Hyogo Medical University, Kobe, Japan.
- School of Pharmacy, Hyogo Medical University, Kobe, Japan shimizu-t@hyo-med.ac.jp.
Zitieren
APA
Uemichi, Y., Yasuda, S., Mabuchi, M., Nakao, S., Nagano, S., & Shimizu, T. (2025). Effects of Azelastine on Glioblastoma Cells. Anticancer Research. https://doi.org/10.21873/anticanres.17645
Vancouver
Uemichi Y, Yasuda S, Mabuchi M, Nakao S, Nagano S, Shimizu T. Effects of Azelastine on Glioblastoma Cells. Anticancer Research. 2025. doi:10.21873/anticanres.17645
BibTeX
@article{Uemichi2025,
author = {Uemichi, Yuki and Yasuda, Seina and Mabuchi, Miyuki and Nakao, Shuhei and Nagano, Shuji and Shimizu, Tadashi},
title = {Effects of Azelastine on Glioblastoma Cells},
journal = {Anticancer Research},
year = {2025},
doi = {10.21873/anticanres.17645}
}
EUVIMED